
IM PGY1 @MayoClinic | MD @MayoClinicSOM, PhD @MayoGradSchool | Interested in genetic cardiology, epigenetics, omics, and molecular pharmacology | Views my own
Joined May 2020
- Tweets210
- Following295
- Followers302
- Likes860
Ramin Garmany retweeted
Quite the #AHA2026 hat trick! 🎯
Grateful for the opportunity to share some of our work today.
Big thanks to my mentors @JohnGiudicessi @MJAckermanMDPhD and to the whole team. @MayoClinicWSRGH @MCastrichiniMD @GarmanyRamin
Now we keep pushing!
#ScientificSessions26
Last day of #AHA2026, but @GiovanniMultinu is going strong with not 1 but 3 presentations covering the role of transmural LGE, LV hypertrabeculation and myocarditis episodes in genotype-positive ACM/DCM in the same cardiomyopathy session. @MayoClinicCV @MayoClinicWSRGH
Grateful to present our study from @MayoClinicCV at #ESCCongress in Munich showing an increased AI ECG Age Gap Predicts Risk of Heart Failure Events in Patients with PKP2-cardiomyopathy! @JohnGiudicessi @MJAckermanMDPhD @MCastrichiniMD – at Munich, Germany
Ramin Garmany retweeted
More work from the Mayo Genetic Cardiomyopathy/ACM team! Doesn’t matter the cardiomyopathy, having >1 P/LP variant is associated with worse outcomes. Congrats to Dr. Nouraee @MayoMN_IMRES and thanks to @hrs_journal @MayoClinicCV @MayoClinicWSRGH.
Clinical Characteristics and Prognostic Impact of Multiple Pathogenic Variants Across the Genetic Spectrum of Arrhythmogenic and Dilated Cardiomyopathies
@JohnGiudicessi
heartrhythmjournal.com/artic…
Ramin Garmany retweeted
Not all transmural LGE on cardiac MRI is ischemic. 5% of ACM/DCM patients, primarily those with P/LP variants in LMNA and DSP, have transmural LGE and represent a high-risk subset. @JACCJournals @MayoClinicCV @MCastrichiniMD @GarmanyRamin @GiovanniMultinu jacc.org/doi/10.1016/j.jacep…
Ramin Garmany retweeted
So proud of 3 MD/PhD students from @MayoClinicSOM & @MayoGradSchool who graduated yesterday. Sahej and her PhD work on #gene #therapy for #LQTS & Ramin and his work on #HCM over these past 6+ years has been so appreciated. And Jake (far left) is married to one of my scientists 🤗
Ramin Garmany retweeted
Strong work @MCastrichiniMD and
big thanks to the nearly 1,500 genotype-positive ACM/DCM patients/families in our @MayoClinicCV @MayoClinicWSRGH Genetic Cardiomyopathy registry who made this and exciting ongoing work possible!
PKP2-ACM patients display a distinct recovery phase arrhythmic profile predictive of MVA events, emphasizing the importance of EST in risk stratification and management. Future studies are needed jacc.org/doi/10.1016/j.jacep… #JACCCEP #EPeeps #Cardiomyopathy @JohnGiudicessi
Ramin Garmany retweeted
🔥 Thrilled to share our most recent study on the outcomes of VT ablation for LMNA Cardiomyopathy 🫀⚡️
📌 Despite ablation, rates of recurrent VT and death were remarkably elevated.
🙏🏽 Huge thanks to the team @MCastrichiniMD @VizentinVanessa @JohnGiudicessi @MJAckermanMDPhD
Ramin Garmany retweeted
Big shootout to Dr. Reid Schlesinger an @MayoMN_IMRES resident for his work on the potential role of variant type in ventricular arrhythmias in RBM20-related cardiomyopathy that was published simultaneously in @JACCJournals during AHA! jacc.org/doi/10.1016/j.jacep…
Ramin Garmany retweeted
🚨PKP2-ACM patients show a distinct recovery-phase arrhythmic profile on EST—predictive of major ventricular arrhythmias.
Read more 👉jacc.org/doi/10.1016/j.jacep…
@MayoCVFellows @MayoClinicCV #CardioTwitter #EPeeps
Arrhythmias in recovery are usually not a good sign. This example here is in PKP2. Others have shown in other diseases. Is PKP2 distinct from DSP or is it an issue of sample size and selection
jacc.org/doi/10.1016/j.jacep…
#cardiotwitter
Ramin Garmany retweeted
Excited and grateful to share our paper describing how KCTD10 detects collisions between replication and transcription. Huge thanks to my mentors, collaborators, and reviewers who made this possible! @Nature @MayoClinic
nature.com/articles/s41586-0…
Ramin Garmany retweeted
PKP2-ACM is associated with a distinct ventricular arrhythmia pattern on exercise stress test that may carry prognostic significance. Strong work in @JACCJournals from @MayoClinicCV fellow @MCastrichiniMD and the @MayoClinicWSRGH team! authors.elsevier.com/a/1ljK1…
Ramin Garmany retweeted
🚨 New @CircAHA #ESC2025 #SimPub alert!
🚨 HCM isn’t just driven by rare Mendelian mutations. This study highlights the role of intermediate-effect variants (IEVs)—variants with moderate effect & low penetrance—in shaping disease expression. #HCM
tinyurl.com/HCM-IEVs
Ramin Garmany retweeted
In cardiac laminopathy, missense variants in the IgD domain show a unique "pseudo-infarct" pattern on MRI, with higher risk of ventricular arrhythmias and stroke. #AHAJournals @MCastrichiniMD @MJAckermanMDPhD @JohnGiudicessi @MayoClinicCV ahajrnls.org/45q1x9n
Ramin Garmany retweeted
📣 📣 Don’t miss our oral presentation at #HeartRhythm2025 in San Diego!
“Prognostic Significance of Exercise Stress Testing in Desmosomal ACM”
April 25 | Hub 5 | Sails Pavilion
@JohnGiudicessi @MJAckermanMDPhD
@MayoEPFellows @MayoCVFellows
#EPeeps #HRS2025
Let’s talk rhythm!🫀🎶
Ramin Garmany retweeted
RBM20 cardiomyopathy carries a more significant burden at a younger age, and an accelerated course compared to TTN cardiomyopathy
pmc.ncbi.nlm.nih.gov/article…
#CardioTwitter
Ramin Garmany retweeted
Strong work @swain_willMD, @MCastrichiniMD, @GarmanyRamin and the @MayoClinicCV Genetic Cardiomyopathy research team!!! Much more to come from these talented future Cardiologists/Genetic Cardiologists.
Prevalence, characteristics, and outcomes of genotype-positive arrhythmogenic cardiomyopathy presenting with sentinel cardiac arrest
@JohnGiudicessi
heartrhythmjournal.com/artic…
Ramin Garmany retweeted
Glad to see our @JAMANetworkOpen study out. The study brings attention to the growing healthspan-lifespan gap across the world and reveals the largest gap in the US. The study documents a larger healthspan-lifespan gap in women associated with a disease burden disparity.
The global healthspan-lifespan gap has widened to 9.6 years over the past two decades, with women experiencing a larger gap than men, and is associated with increased noncommunicable diseases and overall morbidity, particularly in the US. ja.ma/4inyvwV
Ramin Garmany retweeted
From Dan Ye + @MJAckermanMDPhD: Clinical Utility of Protein Language Models in Resolution of VUSs in KCNQ1, KCNH2, and SCN5A Compared to Patch Clamp Functional Characterization
ahajournals.org/doi/abs/10.1…
@AHAScience #AHAjournals #CardioTwitter #Genetics
🎥@hj_tadros
Happy to see our manuscript characterizing sex-specific differences in the multi-omics profile of HCM officially published! Grateful to @MJAckermanMDPhD and my co-authors for making this possible. sciencedirect.com/science/ar…
Congrats @ArminGarmany!
.@MayoClinic research is investigating the health effects of space travel on private citizens. A @MayoProceedings @ArminGarmany paper shares findings of the health response of the first all-civilian astronaut mission to the International Space Station.
mayocl.in/3MEkZWJ
10
499



































